A rare case of Salmonella Infantis urinary tract infection in a high-risk elderly patient
DOI:
https://doi.org/10.63719/imrj.2026.12.01.007Abstract
Salmonella spp. are predominantly recognized as enteric pathogens, while urinary tract infection represents a rare extraintestinal manifestation, often indicating underlying host vulnerability. This report describes a case of urinary tract infection in a 63-year-old male with multiple predisposing factors, including chronic hepatitis B and C infection, prolonged immobilization, a grade IV sacral pressure injury, and prior prolonged hospitalization. The patient presented with fever, lethargy, and persistent urinary symptoms. Although initial urine microscopy showed no visible bacteria, subsequent urine culture yielded Salmonella spp. Further identification of the isolate was performed using the API® (Analytical Profile Index) system, which identified it as S. infantis. Simultaneously, blood cultures isolated ESBL-producing Escherichia coli, suggesting a complex systemic co-infection. Antimicrobial susceptibility testing revealed that S. infantis was resistant to ceftriaxone but susceptible to fluoroquinolones. Initial empirical therapy with IV Ceftriaxone was unsuccessful; however, targeted therapy with IV Ciprofloxacin 400mg BD for 14 days led to clinical stabilization within 48 hours. This case highlights the importance of considering atypical pathogens such as S, infantis in urinary tract infections, particularly in high-risk and immunocompromised patients. Early microbiological identification and susceptibility testing are essential for appropriate management and improved clinical outcomes. In conclusion, accurate microbiological diagnosis plays a critical role in the management of unusual urinary tract infections, especially in complex patients with multiple comorbidities.
References
Uehara Y, Takada S, Nakahama C, Yoshinari K. Salmonella spp. Urinary tract infection in an elderly patient: A case report and review of the literature. J Infect Chemother. 2021;27(10):1495-9.
Tena D, González-Praetorius A, Bisquert J. Urinary tract infection due to non-typhoidal Salmonella spp.: Report of 19 cases. J Infect. 2007;54(6):e245-9.
Abbot S, Tille P. Clinical microbiology procedures handbook. 4th ed. Washington, DC: ASM Press; 2016.
Ramos JM, Aguado JM, García-Corbeira P, Alés JM, Soriano F. Clinical spectrum of urinary tract infections due to Salmonella spp. species. Clin Infect Dis. 1996;23(2):388-90.
World Health Organization. Non-typhoidal Salmonella spp. [Internet]. Geneva: WHO; 2023 [cited 2026 Feb 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/Salmonella spp.-(non-typhoidal)
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 33rd ed. Wayne, PA: CLSI; 2023. CLSI supplement M100.
Sanclemente G, Garcia-Fullana A, Pedro-Botet ML. Extraintestinal manifestations of non-typhoidal Salmonella spp.: A focus on rare sites. Eur J Clin Microbiol Infect Dis. 2020;39(11):2045-52.
Soni S, Sharma J, Soni BK. Salmonella spp. urinary tract infection in a patient with chronic kidney disease. J Clin Diagn Res. 2018;12(5):LD01-03.
Patil MS, Sreeramulu J. Challenges in the diagnosis and management of atypical uropathogens. Int J Med Res. 2022;14(3):88-95.
Centers for Disease Control and Prevention. Salmonella spp. (non-typhoidal) surveillance and antimicrobial resistance [Internet]. Atlanta: CDC; 2024 [cited 2026 Feb 24]. Available from: https://www.cdc.gov/Salmonella spp./index.html
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.


